Form 4: Cargo Therapeutics CFO Acquires 40,000 Stock Options

Anup Radhakrishnan, CFO of Cargo Therapeutics, acquired 40,000 stock options with a $16 exercise price, vesting monthly over four years.

Summary

• Anup Radhakrishnan, the Chief Financial Officer and Chief Operating Officer of Cargo Therapeutics, Inc., has acquired 40,000 stock options.
• The options have an exercise price of $16 per share.
• The options vest monthly over four years, starting from November 12, 2024.
• The options will be fully vested and exercisable on the fourth anniversary of the vesting commencement date, November 12, 2028.
• The options expire on November 14, 2034.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management's interests with shareholders. The sentiment is neutral to positive.

Positives

• The acquisition of stock options by a key executive like the CFO can be seen as a positive sign of confidence in the company's future performance.
• The vesting schedule aligns the executive's interests with the long-term success of the company.

Risks

• The value of the options is dependent on the future performance of the company's stock price.
• If the stock price does not increase above the exercise price of $16, the options may not be valuable.

Future Outlook

The vesting schedule of the options suggests a long-term commitment from the CFO to the company's success.

Management Comments

• The filing was signed by Halley Gilbert, as attorney-in-fact for Anup Radhakrishnan.

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with shareholder value creation.

Comparison to Industry Standards

• Stock option grants are a standard practice for executive compensation in the biotech industry.
• The four-year vesting schedule is typical for such grants, aligning executive incentives with long-term company performance.
• The exercise price of $16 is a specific value that would need to be compared to the current market price of the stock to assess its immediate value.

Stakeholder Impact

• The stock option grant could positively impact shareholder confidence by demonstrating the CFO's commitment to the company's long-term success.
• The grant could also motivate the CFO to work towards increasing the company's value.

Key Dates

Keywords

stock options, insider trading, executive compensation, CFO, Cargo Therapeutics, CRGX, Anup Radhakrishnan